Search

Author/Creator Bultinck, Jennyfer

1. A safe and highly efficient tumor-targeted type I interferon immunotherapy depends on the tumor microenvironment. (4th March 2018)

Authors:
Cauwels, Anje; Van Lint, Sandra; Garcin, Geneviève; Bultinck, Jennyfer; Paul, Franciane; Gerlo, Sarah; Van der Heyden, José; Bordat, Yann; Catteeuw, Dominiek; De Cauwer, Lode; Rogge, Elke; Verhee, Annick; Uzé, Gilles; Tavernier, Jan
Journal:
Oncoimmunology
Issue:
Volume 7:Number 3(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Safe eradication of large established tumors using neovasculature‐targeted tumor necrosis factor‐based therapies. Issue 2 (8th January 2020)

Authors:
Huyghe, Leander; Van Parys, Alexander; Cauwels, Anje; Van Lint, Sandra; De Munter, Stijn; Bultinck, Jennyfer; Zabeau, Lennart; Hostens, Jeroen; Goethals, An; Vanderroost, Nele; Verhee, Annick; Uzé, Gilles; Kley, Niko; Peelman, Frank; Vandekerckhove, Bart; Brouckaert, Peter; Tavernier, Jan
Journal:
EMBO molecular medicine
Issue:
Volume 12:Issue 2(2020)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search